Acsl-1 gene modulation may be a potential therapeutic strategy in obesity-related cardiomyopathy and Acsl-1 haploinsufficiency resulted in normalization of cardiac lipid storage in db/db mice (90). The gene discussed is ACSL1; the disease is obesity due to melanocortin 4 receptor deficiency.